Regeneron Pharmaceuticals, Inc. United States of America (USA)

Research

Date range: 1 April 2021 - 31 March 2022

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Regeneron Pharmaceuticals, Inc. published between 1 April 2021 - 31 March 2022 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for Regeneron Pharmaceuticals, Inc.
Count Share
32 13.91

Outputs by subject (Share)

Outputs by subject
Subject Count Share
28 9.91
4 4.00
1 0.20

Share output for the past 5 years

Share per year
2016 2017 2018 2019 2020
4.57 4.95 8.00 5.35 13.98

Compare Regeneron Pharmaceuticals, Inc. with other institutions

Collaboration

Date range: 1 April 2021 - 31 March 2022

International vs. domestic collaboration by Share

  • 50.84% Domestic
  • 49.16% International

Hover over the graph to view the percentage of collaboration.


Top 10 domestic collaborators with Regeneron Pharmaceuticals, Inc. by Share (101 total)

  1. Regeneron Pharmaceuticals, Inc. and Geisinger Health System (GHS) (3.84)
    Regeneron Pharmaceuticals, Inc.3.35
    Geisinger Health System (GHS)0.49
  2. Regeneron Pharmaceuticals, Inc. and University of Pennsylvania (Penn) (2.23)
    Regeneron Pharmaceuticals, Inc.2.00
    University of Pennsylvania (Penn)0.23
  3. Regeneron Pharmaceuticals, Inc. and Harvard University (1.96)
    Regeneron Pharmaceuticals, Inc.1.66
    Harvard University0.30
  4. Regeneron Pharmaceuticals, Inc. and National Institutes of Health (NIH) (1.87)
    Regeneron Pharmaceuticals, Inc.1.05
    National Institutes of Health (NIH)0.83
  5. Regeneron Pharmaceuticals, Inc. and Broad Institute of MIT and Harvard (1.80)
    Regeneron Pharmaceuticals, Inc.1.59
    Broad Institute of MIT and Harvard0.21
  6. Regeneron Pharmaceuticals, Inc. and Massachusetts Institute of Technology (MIT) (1.70)
    Regeneron Pharmaceuticals, Inc.1.59
    Massachusetts Institute of Technology (MIT)0.11
  7. Regeneron Pharmaceuticals, Inc. and Mount Sinai Health System (MSHS) (1.54)
    Regeneron Pharmaceuticals, Inc.0.07
    Mount Sinai Health System (MSHS)1.46
  8. Regeneron Pharmaceuticals, Inc. and Pfizer Inc. (1.29)
    Regeneron Pharmaceuticals, Inc.1.13
    Pfizer Inc.0.17
  9. Regeneron Pharmaceuticals, Inc. and Alnylam Pharmaceuticals, Inc. (1.19)
    Regeneron Pharmaceuticals, Inc.1.06
    Alnylam Pharmaceuticals, Inc.0.13
  10. Regeneron Pharmaceuticals, Inc. and University of California, Los Angeles (UCLA) (1.18)
    Regeneron Pharmaceuticals, Inc.0.90
    University of California, Los Angeles (UCLA)0.28

Top 10 international collaborators with Regeneron Pharmaceuticals, Inc. by Share (318 total)

  1. Regeneron Pharmaceuticals, Inc. and Lund University (LU) (1.87)
    Regeneron Pharmaceuticals, Inc.1.44
    Lund University (LU)0.43
  2. Regeneron Pharmaceuticals, Inc. and Karolinska Institute (KI) (1.63)
    Regeneron Pharmaceuticals, Inc.0.80
    Karolinska Institute (KI)0.82
  3. Regeneron Pharmaceuticals, Inc. and National Autonomous University of Mexico (UNAM) (1.50)
    Regeneron Pharmaceuticals, Inc.1.39
    National Autonomous University of Mexico (UNAM)0.11
  4. Regeneron Pharmaceuticals, Inc. and University of Oxford (1.48)
    Regeneron Pharmaceuticals, Inc.1.32
    University of Oxford0.16
  5. Regeneron Pharmaceuticals, Inc. and Genomics England Ltd. (0.82)
    Regeneron Pharmaceuticals, Inc.0.50
    Genomics England Ltd.0.32
  6. Regeneron Pharmaceuticals, Inc. and Amsterdam UMC (0.82)
    Regeneron Pharmaceuticals, Inc.0.77
    Amsterdam UMC0.04
  7. Regeneron Pharmaceuticals, Inc. and VU Amsterdam (0.80)
    Regeneron Pharmaceuticals, Inc.0.77
    VU Amsterdam0.03
  8. Regeneron Pharmaceuticals, Inc. and University of Amsterdam (UvA) (0.79)
    Regeneron Pharmaceuticals, Inc.0.77
    University of Amsterdam (UvA)0.02
  9. Regeneron Pharmaceuticals, Inc. and BioNTech AG (0.79)
    Regeneron Pharmaceuticals, Inc.0.06
    BioNTech AG0.72
  10. Regeneron Pharmaceuticals, Inc. and The University of Edinburgh (0.78)
    Regeneron Pharmaceuticals, Inc.0.50
    The University of Edinburgh0.28